Page last updated: 2024-11-01

omeprazole and Premature Birth

omeprazole has been researched along with Premature Birth in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lattey, K1
Quinn, S1
O'Brien, K1

Other Studies

1 other study available for omeprazole and Premature Birth

ArticleYear
Over-the-counter antacids linked to severe hypokalaemia in the context of threatened preterm labour.
    BMJ case reports, 2021, Jan-11, Volume: 14, Issue:1

    Topics: Adult; Antacids; Cardiotocography; Drug Overdose; Female; Gastroesophageal Reflux; Humans; Hypokalem

2021